Using shRNA technology we were able to determine that in VEGF/c-myc mutated cancer cells and in the context of breast cancer, CD24 could serve as a key marker to identify a subpopulation of tumorigenic cancer cells, however it is not functionally involved in the induction of mitogenic pathways. This evidence concerns the gene VEGFA and breast cancer.